137 related articles for article (PubMed ID: 26342032)
1. Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb.
Georgoutsou-Spyridonos M; Ricklin D; Pratsinis H; Perivolioti E; Pirmettis I; Garcia BL; Geisbrecht BV; Foukas PG; Lambris JD; Mastellos DC; Sfyroera G
J Immunol; 2015 Oct; 195(8):3946-58. PubMed ID: 26342032
[TBL] [Abstract][Full Text] [Related]
2. The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus.
Shannon O; Uekotter A; Flock JI
Scand J Immunol; 2006 Mar; 63(3):184-90. PubMed ID: 16499571
[TBL] [Abstract][Full Text] [Related]
3. Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface.
Ko YP; Kuipers A; Freitag CM; Jongerius I; Medina E; van Rooijen WJ; Spaan AN; van Kessel KP; Höök M; Rooijakkers SH
PLoS Pathog; 2013; 9(12):e1003816. PubMed ID: 24348255
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.
Koch TK; Reuter M; Barthel D; Böhm S; van den Elsen J; Kraiczy P; Zipfel PF; Skerka C
PLoS One; 2012; 7(10):e47638. PubMed ID: 23071827
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses.
Jongerius I; von Köckritz-Blickwede M; Horsburgh MJ; Ruyken M; Nizet V; Rooijakkers SH
J Innate Immun; 2012; 4(3):301-11. PubMed ID: 22327617
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation.
Skjeflo EW; Christiansen D; Fure H; Ludviksen JK; Woodruff TM; Espevik T; Nielsen EW; Brekke OL; Mollnes TE
J Thromb Haemost; 2018 May; 16(5):905-918. PubMed ID: 29437288
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.
Ricklin D; Ricklin-Lichtsteiner SK; Markiewski MM; Geisbrecht BV; Lambris JD
J Immunol; 2008 Dec; 181(11):7463-7. PubMed ID: 19017934
[TBL] [Abstract][Full Text] [Related]
8. A structural basis for complement inhibition by Staphylococcus aureus.
Hammel M; Sfyroera G; Ricklin D; Magotti P; Lambris JD; Geisbrecht BV
Nat Immunol; 2007 Apr; 8(4):430-7. PubMed ID: 17351618
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal complement evasion by various convertase-blocking molecules.
Jongerius I; Köhl J; Pandey MK; Ruyken M; van Kessel KP; van Strijp JA; Rooijakkers SH
J Exp Med; 2007 Oct; 204(10):2461-71. PubMed ID: 17893203
[TBL] [Abstract][Full Text] [Related]
10. Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice.
van den Berg S; de Vogel CP; van Belkum A; Bakker-Woudenberg IA
PLoS One; 2015; 10(6):e0129150. PubMed ID: 26060995
[TBL] [Abstract][Full Text] [Related]
11. A novel peptide can mimic extracellular fibrinogen-binding protein to block the activation of complement system.
Gao YP; Dong J; Zhang X; Liu Y; Lu Q; Feng JN; Tan XR; Yang G
Cell Biochem Biophys; 2013 Jul; 66(3):753-7. PubMed ID: 23420525
[TBL] [Abstract][Full Text] [Related]
12. The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.
Kuipers A; Stapels DAC; Weerwind LT; Ko YP; Ruyken M; Lee JC; van Kessel KPM; Rooijakkers SHM
Microbiology (Reading); 2016 Jul; 162(7):1185-1194. PubMed ID: 27112346
[TBL] [Abstract][Full Text] [Related]
13. Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.
Brown EL; Nishiyama Y; Dunkle JW; Aggarwal S; Planque S; Watanabe K; Csencsits-Smith K; Bowden MG; Kaplan SL; Paul S
J Biol Chem; 2012 Mar; 287(13):9940-9951. PubMed ID: 22303018
[TBL] [Abstract][Full Text] [Related]
14. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
15. Method for generation of peptide-specific IgY antibodies directed to Staphylococcus aureus extracellular fibrinogen binding protein epitope.
Walczak M; Grzywa R; Łupicka-Słowik A; Skoreński M; Bobrek K; Nowak D; Boivin S; Brown EL; Oleksyszyn J; Sieńczyk M
Biopolymers; 2015 Sep; 104(5):552-9. PubMed ID: 26095000
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement activation by a secreted Staphylococcus aureus protein.
Lee LY; Höök M; Haviland D; Wetsel RA; Yonter EO; Syribeys P; Vernachio J; Brown EL
J Infect Dis; 2004 Aug; 190(3):571-9. PubMed ID: 15243934
[TBL] [Abstract][Full Text] [Related]
17. Immunization routes in cattle impact the levels and neutralizing capacity of antibodies induced against S. aureus immune evasion proteins.
Boerhout E; Vrieling M; Benedictus L; Daemen I; Ravesloot L; Rutten V; Nuijten P; van Strijp J; Koets A; Eisenberg S
Vet Res; 2015 Sep; 46():115. PubMed ID: 26411347
[TBL] [Abstract][Full Text] [Related]
18. Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.
Haspel N; Ricklin D; Geisbrecht BV; Kavraki LE; Lambris JD
Protein Sci; 2008 Nov; 17(11):1894-906. PubMed ID: 18687868
[TBL] [Abstract][Full Text] [Related]
19. Role for the fibrinogen-binding proteins coagulase and Efb in the Staphylococcus aureus-Candida interaction.
Fehrmann C; Jurk K; Bertling A; Seidel G; Fegeler W; Kehrel BE; Peters G; Becker K; Heilmann C
Int J Med Microbiol; 2013 Jul; 303(5):230-8. PubMed ID: 23684234
[TBL] [Abstract][Full Text] [Related]
20. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
Schennings T; Farnebo F; Szekely L; Flock JI
APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
